ConductScience.org, home

Paper9740539

Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro.

Etievant C and 4 others. Invest New Drugs, 1998. Cited by 70 papers, by iCite.

Cite this record

ConductScience Library. Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro. Papers, record 9740539. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9740539

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro.
PubMed
Journal
Invest New Drugs
PubMed
Year
1998
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
70
iCite
Relative citation ratio, by iCite
1.97
iCite
Revised in PubMed
2026-10-16
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Etievant CC
2Barret JMJ M
3Kruczynski AA
4Perrin DD
5Hill BTB T

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ATP Binding Cassette Transporter, Subfamily B, Member 1Major topic
Antineoplastic Agents, PhytogenicMajor topic
Drug Resistance, MultipleMajor topic
VinblastineMajor topic
Animals
Calcium Channel Blockers
Doxorubicin
Drug Resistance, Neoplasm
Female
Humans
Leukemia P388
Mice
Mice, Inbred BALB C
Mice, Inbred DBA
Phenotype
Tumor Cells, Cultured
Verapamil

Source PubMed

Download CSV of topics

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11967222Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line.Cancer Res1990https://conductscience.org/library/papers/1967222PubMed
22853972Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26.Biochemistry1988https://conductscience.org/library/papers/2853972PubMed
31360704Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.Science1992https://conductscience.org/library/papers/1360704PubMed
48102521Biochemistry of multidrug resistance mediated by the multidrug transporter.Annu Rev Biochem1993https://conductscience.org/library/papers/8102521PubMed
5942051A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal Biochem1976https://conductscience.org/library/papers/942051PubMed
69815698Phase I and pharmacological study of CI-980, a novel synthetic antimicrotubule agent.Clin Cancer Res1997https://conductscience.org/library/papers/9815698PubMed
77954400Detection of the M(r) 190,000 multidrug resistance protein, MRP, with monoclonal antibodies.Cancer Res1994https://conductscience.org/library/papers/7954400PubMed
86606682Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.J Immunol Methods1983https://conductscience.org/library/papers/6606682PubMed
98270613Digital cell image analysis of verapamil-induced effects in chemosensitive and chemoresistant neoplastic cell lines.J Cancer Res Clin Oncol1993https://conductscience.org/library/papers/8270613PubMed
103540935Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats.Proc Natl Acad Sci U S A1986https://conductscience.org/library/papers/3540935PubMed
118621643Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport.J Biol Chem1996https://conductscience.org/library/papers/8621643PubMed
121349840Why haven't we cured multidrug resistant tumors?Oncol Res1992https://conductscience.org/library/papers/1349840PubMed
137949466Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug-resistant MCF-7 cells.Oncol Res1994https://conductscience.org/library/papers/7949466PubMed
142436751Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.Cancer Res1987https://conductscience.org/library/papers/2436751PubMed
157323809Preclinical drug development: rationale and methods.Semin Oncol1981https://conductscience.org/library/papers/7323809PubMed
161935454Digital morphonuclear analyses of sensitive versus resistant neoplastic cells to vinca-alkaloid, alkylating, and intercalating drugs.Cytometry1991https://conductscience.org/library/papers/1935454PubMed
177105380Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/7105380PubMed
188866664Novel mechanism of resistance to paclitaxel (Taxol) in human K562 leukemia cells by combined selection with PSC 833.Oncol Res1995https://conductscience.org/library/papers/8866664PubMed
195432063Cleavage of structural proteins during the assembly of the head of bacteriophage T4.Nature1970https://conductscience.org/library/papers/5432063PubMed
209554586Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid.Cancer Chemother Pharmacol1998https://conductscience.org/library/papers/9554586PubMed

See all 62 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.

PMIDTitleJournalYearIn PapersSource
42582698Unique fluoroalkyl substituents: is there life after CF3?Chem Sci2026https://conductscience.org/library/papers/42582698PubMed
37513450Therapeutic Role of Alkaloids and Alkaloid Derivatives in Cancer Management.Molecules2023https://conductscience.org/library/papers/37513450PubMed
29251920Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment.J Med Chem2018https://conductscience.org/library/papers/29251920PubMed
26055179Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics.Transl Oncol2015https://conductscience.org/library/papers/26055179PubMed
24871553A new lipid-based nano formulation of vinorelbine.AAPS PharmSciTech2014https://conductscience.org/library/papers/24871553PubMed
24822174Cancer wars: natural products strike back.Front Chem2014https://conductscience.org/library/papers/24822174PubMed
24198619Critical evaluation of vinflunine in the treatment of refractory metastatic urothelial carcinoma.Open Access J Urol2010https://conductscience.org/library/papers/24198619PubMed
22471295Vinflunine oral pharmacokinetics and absolute bioavailability of soft and hard gelatin capsules: results of two phase I trials.Clin Pharmacokinet2012https://conductscience.org/library/papers/22471295PubMed
20703895Beta-casein nanoparticles as an oral delivery system for chemotherapeutic drugs: impact of drug structure and properties on co-assembly.Pharm Res2010https://conductscience.org/library/papers/20703895PubMed
20568834Vinflunine.Drugs2010https://conductscience.org/library/papers/20568834PubMed
19337431Vinflunine in the treatment of bladder cancer.Ther Clin Risk Manag2008https://conductscience.org/library/papers/19337431PubMed
18312675Comparative study of the radiosensitizing and cell cycle effects of vinflunine and vinorelbine, in vitro.BMC Cancer2008https://conductscience.org/library/papers/18312675PubMed
18071633Murine leukemia P388 vinorelbine-resistant cell lines are sensitive to vinflunine.Invest New Drugs2008https://conductscience.org/library/papers/18071633PubMed
16898072Pharmacokinetics, tissue distribution and excretion of vinflunine.Eur J Drug Metab Pharmacokinet2006https://conductscience.org/library/papers/16898072PubMed
16211365Phase I study of vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeks.Invest New Drugs2006https://conductscience.org/library/papers/16211365PubMed
12381238Vinorelbine: a review of its use in elderly patients with advanced non-small cell lung cancer.Drugs Aging2002https://conductscience.org/library/papers/12381238PubMed
11857026Characterization of cell death induced by vinflunine, the most recent Vinca alkaloid in clinical development.Br J Cancer2002https://conductscience.org/library/papers/11857026PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
PGP283871PubTator's text mininghttps://conductscience.org/library/genes/283871NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9740539

GET https://conductscience.org/api/papers/v1/9740539/references?page=2